The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Anal and Colorectal Cancer-Global Market Insights and Sales Trends 2025
Synopsis
The global Anal and Colorectal Cancer market size is expected to reach US$ million by 2029, growing at a CAGR of % from 2023 to 2029. The market is mainly driven by the significant applications of Anal and Colorectal Cancer in various end use industries. The expanding demands from the Hospitals, Ambulatory surgery centers and Cancer research centers,, are propelling Anal and Colorectal Cancer market. Surgery, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Radiation therapy segment is estimated at % CAGR for the next seven-year period.
Asia Pacific shows high growth potential for Anal and Colorectal Cancer market, driven by demand from China, the second largest economy with some signs of stabilising, the Anal and Colorectal Cancer market in China is forecast to reach US$ million by 2029, trailing a CAGR of % over the 2023-2029 period, while the U.S. market will reach US$ million by 2029, exhibiting a CAGR of % during the same period.
Report Objectives
This report provides market insight on the different segments, by players, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Anal and Colorectal Cancer, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Anal and Colorectal Cancer market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Anal and Colorectal Cancer market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Anal and Colorectal Cancer sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Anal and Colorectal Cancer covered in this report include Abbott Diagnostics, Advaxis, Abbott, Amgen, Atara Biotherapeutics, Bayer, Metabiomics, Beckman Coulter and BeiGene, etc.
The global Anal and Colorectal Cancer market report caters to various stakeholders in this industry including investors, suppliers, product players, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Abbott Diagnostics
Advaxis
Abbott
Amgen
Atara Biotherapeutics
Bayer
Metabiomics
Beckman Coulter
BeiGene
Boehringer Ingelheim
Clinical Genomics
EDP Biotech
Eli Lilly
Epigenomics
Exact Sciences
Genomictree
Immunovaccine
ISA Pharmaceuticals
Merck
Global Anal and Colorectal Cancer market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Anal and Colorectal Cancer market, Segment by Type:
Surgery
Radiation therapy
Colorectal cancer chemotherapy
Targeted therapy
Immunotherapy
Global Anal and Colorectal Cancer market, by Application
Hospitals
Ambulatory surgery centers
Cancer research centers
Core Chapters
Chapter One: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2018-2023, 2024-2029). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter Two: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter Three: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter Four: Detailed analysis of Anal and Colorectal Cancer companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Five: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter Six, Seven, Eight, Nine and Ten: North America, Europe, Asia Pacific, Latin America, Middle East & Africa, revenue by country.
Chapter Eleven: this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Research Finding/Conclusion
The global Anal and Colorectal Cancer market size is expected to reach US$ million by 2029, growing at a CAGR of % from 2023 to 2029. The market is mainly driven by the significant applications of Anal and Colorectal Cancer in various end use industries. The expanding demands from the Hospitals, Ambulatory surgery centers and Cancer research centers,, are propelling Anal and Colorectal Cancer market. Surgery, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Radiation therapy segment is estimated at % CAGR for the next seven-year period.
Asia Pacific shows high growth potential for Anal and Colorectal Cancer market, driven by demand from China, the second largest economy with some signs of stabilising, the Anal and Colorectal Cancer market in China is forecast to reach US$ million by 2029, trailing a CAGR of % over the 2023-2029 period, while the U.S. market will reach US$ million by 2029, exhibiting a CAGR of % during the same period.
Report Objectives
This report provides market insight on the different segments, by players, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Anal and Colorectal Cancer, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Anal and Colorectal Cancer market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Anal and Colorectal Cancer market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Anal and Colorectal Cancer sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Anal and Colorectal Cancer covered in this report include Abbott Diagnostics, Advaxis, Abbott, Amgen, Atara Biotherapeutics, Bayer, Metabiomics, Beckman Coulter and BeiGene, etc.
The global Anal and Colorectal Cancer market report caters to various stakeholders in this industry including investors, suppliers, product players, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Abbott Diagnostics
Advaxis
Abbott
Amgen
Atara Biotherapeutics
Bayer
Metabiomics
Beckman Coulter
BeiGene
Boehringer Ingelheim
Clinical Genomics
EDP Biotech
Eli Lilly
Epigenomics
Exact Sciences
Genomictree
Immunovaccine
ISA Pharmaceuticals
Merck
Global Anal and Colorectal Cancer market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Anal and Colorectal Cancer market, Segment by Type:
Surgery
Radiation therapy
Colorectal cancer chemotherapy
Targeted therapy
Immunotherapy
Global Anal and Colorectal Cancer market, by Application
Hospitals
Ambulatory surgery centers
Cancer research centers
Core Chapters
Chapter One: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2018-2023, 2024-2029). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter Two: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter Three: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter Four: Detailed analysis of Anal and Colorectal Cancer companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Five: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter Six, Seven, Eight, Nine and Ten: North America, Europe, Asia Pacific, Latin America, Middle East & Africa, revenue by country.
Chapter Eleven: this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Research Finding/Conclusion
Index1 Market Overview of Anal and Colorectal Cancer
1.1 Anal and Colorectal Cancer Market Overview
1.1.1 Anal and Colorectal Cancer Product Scope
1.1.2 Anal and Colorectal Cancer Market Status and Outlook
1.2 Global Anal and Colorectal Cancer Market Size Overview by Region 2018 VS 2022 VS 2029
1.3 Global Anal and Colorectal Cancer Market Size by Region (2018-2029)
1.4 Global Anal and Colorectal Cancer Historic Market Size by Region (2018-2023)
1.5 Global Anal and Colorectal Cancer Market Size Forecast by Region (2024-2029)
1.6 Key Regions, Anal and Colorectal Cancer Market Size (2018-2029)
1.6.1 North America Anal and Colorectal Cancer Market Size (2018-2029)
1.6.2 Europe Anal and Colorectal Cancer Market Size (2018-2029)
1.6.3 Asia-Pacific Anal and Colorectal Cancer Market Size (2018-2029)
1.6.4 Latin America Anal and Colorectal Cancer Market Size (2018-2029)
1.6.5 Middle East & Africa Anal and Colorectal Cancer Market Size (2018-2029)
2 Anal and Colorectal Cancer Market by Type
2.1 Introduction
2.1.1 Surgery
2.1.2 Radiation therapy
2.1.3 Colorectal cancer chemotherapy
2.1.4 Targeted therapy
2.1.5 Immunotherapy
2.2 Global Anal and Colorectal Cancer Market Size by Type: 2018 VS 2022 VS 2029
2.2.1 Global Anal and Colorectal Cancer Historic Market Size by Type (2018-2023)
2.2.2 Global Anal and Colorectal Cancer Forecasted Market Size by Type (2024-2029)
2.3 Key Regions Market Size by Type
2.3.1 North America Anal and Colorectal Cancer Revenue Breakdown by Type (2018-2029)
2.3.2 Europe Anal and Colorectal Cancer Revenue Breakdown by Type (2018-2029)
2.3.3 Asia-Pacific Anal and Colorectal Cancer Revenue Breakdown by Type (2018-2029)
2.3.4 Latin America Anal and Colorectal Cancer Revenue Breakdown by Type (2018-2029)
2.3.5 Middle East and Africa Anal and Colorectal Cancer Revenue Breakdown by Type (2018-2029)
3 Anal and Colorectal Cancer Market Overview by Application
3.1 Introduction
3.1.1 Hospitals
3.1.2 Ambulatory surgery centers
3.1.3 Cancer research centers
3.2 Global Anal and Colorectal Cancer Market Size by Application: 2018 VS 2022 VS 2029
3.2.1 Global Anal and Colorectal Cancer Historic Market Size by Application (2018-2023)
3.2.2 Global Anal and Colorectal Cancer Forecasted Market Size by Application (2024-2029)
3.3 Key Regions Market Size by Application
3.3.1 North America Anal and Colorectal Cancer Revenue Breakdown by Application (2018-2029)
3.3.2 Europe Anal and Colorectal Cancer Revenue Breakdown by Application (2018-2029)
3.3.3 Asia-Pacific Anal and Colorectal Cancer Revenue Breakdown by Application (2018-2029)
3.3.4 Latin America Anal and Colorectal Cancer Revenue Breakdown by Application (2018-2029)
3.3.5 Middle East and Africa Anal and Colorectal Cancer Revenue Breakdown by Application (2018-2029)
4 Anal and Colorectal Cancer Competition Analysis by Players
4.1 Global Anal and Colorectal Cancer Market Size by Players (2018-2023)
4.2 Global Top Players by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Anal and Colorectal Cancer as of 2022)
4.3 Date of Key Players Enter into Anal and Colorectal Cancer Market
4.4 Global Top Players Anal and Colorectal Cancer Headquarters and Area Served
4.5 Key Players Anal and Colorectal Cancer Product Solution and Service
4.6 Competitive Status
4.6.1 Anal and Colorectal Cancer Market Concentration Rate
4.6.2 Mergers & Acquisitions, Expansion Plans
5 Company (Top Players) Profiles
5.1 Abbott Diagnostics
5.1.1 Abbott Diagnostics Profile
5.1.2 Abbott Diagnostics Main Business
5.1.3 Abbott Diagnostics Anal and Colorectal Cancer Products, Services and Solutions
5.1.4 Abbott Diagnostics Anal and Colorectal Cancer Revenue (US$ Million) & (2018-2023)
5.1.5 Abbott Diagnostics Recent Developments
5.2 Advaxis
5.2.1 Advaxis Profile
5.2.2 Advaxis Main Business
5.2.3 Advaxis Anal and Colorectal Cancer Products, Services and Solutions
5.2.4 Advaxis Anal and Colorectal Cancer Revenue (US$ Million) & (2018-2023)
5.2.5 Advaxis Recent Developments
5.3 Abbott
5.3.1 Abbott Profile
5.3.2 Abbott Main Business
5.3.3 Abbott Anal and Colorectal Cancer Products, Services and Solutions
5.3.4 Abbott Anal and Colorectal Cancer Revenue (US$ Million) & (2018-2023)
5.3.5 Amgen Recent Developments
5.4 Amgen
5.4.1 Amgen Profile
5.4.2 Amgen Main Business
5.4.3 Amgen Anal and Colorectal Cancer Products, Services and Solutions
5.4.4 Amgen Anal and Colorectal Cancer Revenue (US$ Million) & (2018-2023)
5.4.5 Amgen Recent Developments
5.5 Atara Biotherapeutics
5.5.1 Atara Biotherapeutics Profile
5.5.2 Atara Biotherapeutics Main Business
5.5.3 Atara Biotherapeutics Anal and Colorectal Cancer Products, Services and Solutions
5.5.4 Atara Biotherapeutics Anal and Colorectal Cancer Revenue (US$ Million) & (2018-2023)
5.5.5 Atara Biotherapeutics Recent Developments
5.6 Bayer
5.6.1 Bayer Profile
5.6.2 Bayer Main Business
5.6.3 Bayer Anal and Colorectal Cancer Products, Services and Solutions
5.6.4 Bayer Anal and Colorectal Cancer Revenue (US$ Million) & (2018-2023)
5.6.5 Bayer Recent Developments
5.7 Metabiomics
5.7.1 Metabiomics Profile
5.7.2 Metabiomics Main Business
5.7.3 Metabiomics Anal and Colorectal Cancer Products, Services and Solutions
5.7.4 Metabiomics Anal and Colorectal Cancer Revenue (US$ Million) & (2018-2023)
5.7.5 Metabiomics Recent Developments
5.8 Beckman Coulter
5.8.1 Beckman Coulter Profile
5.8.2 Beckman Coulter Main Business
5.8.3 Beckman Coulter Anal and Colorectal Cancer Products, Services and Solutions
5.8.4 Beckman Coulter Anal and Colorectal Cancer Revenue (US$ Million) & (2018-2023)
5.8.5 Beckman Coulter Recent Developments
5.9 BeiGene
5.9.1 BeiGene Profile
5.9.2 BeiGene Main Business
5.9.3 BeiGene Anal and Colorectal Cancer Products, Services and Solutions
5.9.4 BeiGene Anal and Colorectal Cancer Revenue (US$ Million) & (2018-2023)
5.9.5 BeiGene Recent Developments
5.10 Boehringer Ingelheim
5.10.1 Boehringer Ingelheim Profile
5.10.2 Boehringer Ingelheim Main Business
5.10.3 Boehringer Ingelheim Anal and Colorectal Cancer Products, Services and Solutions
5.10.4 Boehringer Ingelheim Anal and Colorectal Cancer Revenue (US$ Million) & (2018-2023)
5.10.5 Boehringer Ingelheim Recent Developments
5.11 Clinical Genomics
5.11.1 Clinical Genomics Profile
5.11.2 Clinical Genomics Main Business
5.11.3 Clinical Genomics Anal and Colorectal Cancer Products, Services and Solutions
5.11.4 Clinical Genomics Anal and Colorectal Cancer Revenue (US$ Million) & (2018-2023)
5.11.5 Clinical Genomics Recent Developments
5.12 EDP Biotech
5.12.1 EDP Biotech Profile
5.12.2 EDP Biotech Main Business
5.12.3 EDP Biotech Anal and Colorectal Cancer Products, Services and Solutions
5.12.4 EDP Biotech Anal and Colorectal Cancer Revenue (US$ Million) & (2018-2023)
5.12.5 EDP Biotech Recent Developments
5.13 Eli Lilly
5.13.1 Eli Lilly Profile
5.13.2 Eli Lilly Main Business
5.13.3 Eli Lilly Anal and Colorectal Cancer Products, Services and Solutions
5.13.4 Eli Lilly Anal and Colorectal Cancer Revenue (US$ Million) & (2018-2023)
5.13.5 Eli Lilly Recent Developments
5.14 Epigenomics
5.14.1 Epigenomics Profile
5.14.2 Epigenomics Main Business
5.14.3 Epigenomics Anal and Colorectal Cancer Products, Services and Solutions
5.14.4 Epigenomics Anal and Colorectal Cancer Revenue (US$ Million) & (2018-2023)
5.14.5 Epigenomics Recent Developments
5.15 Exact Sciences
5.15.1 Exact Sciences Profile
5.15.2 Exact Sciences Main Business
5.15.3 Exact Sciences Anal and Colorectal Cancer Products, Services and Solutions
5.15.4 Exact Sciences Anal and Colorectal Cancer Revenue (US$ Million) & (2018-2023)
5.15.5 Exact Sciences Recent Developments
5.16 Genomictree
5.16.1 Genomictree Profile
5.16.2 Genomictree Main Business
5.16.3 Genomictree Anal and Colorectal Cancer Products, Services and Solutions
5.16.4 Genomictree Anal and Colorectal Cancer Revenue (US$ Million) & (2018-2023)
5.16.5 Genomictree Recent Developments
5.17 Immunovaccine
5.17.1 Immunovaccine Profile
5.17.2 Immunovaccine Main Business
5.17.3 Immunovaccine Anal and Colorectal Cancer Products, Services and Solutions
5.17.4 Immunovaccine Anal and Colorectal Cancer Revenue (US$ Million) & (2018-2023)
5.17.5 Immunovaccine Recent Developments
5.18 ISA Pharmaceuticals
5.18.1 ISA Pharmaceuticals Profile
5.18.2 ISA Pharmaceuticals Main Business
5.18.3 ISA Pharmaceuticals Anal and Colorectal Cancer Products, Services and Solutions
5.18.4 ISA Pharmaceuticals Anal and Colorectal Cancer Revenue (US$ Million) & (2018-2023)
5.18.5 ISA Pharmaceuticals Recent Developments
5.19 Merck
5.19.1 Merck Profile
5.19.2 Merck Main Business
5.19.3 Merck Anal and Colorectal Cancer Products, Services and Solutions
5.19.4 Merck Anal and Colorectal Cancer Revenue (US$ Million) & (2018-2023)
5.19.5 Merck Recent Developments
6 North America
6.1 North America Anal and Colorectal Cancer Market Size by Country (2018-2029)
6.2 U.S.
6.3 Canada
7 Europe
7.1 Europe Anal and Colorectal Cancer Market Size by Country (2018-2029)
7.2 Germany
7.3 France
7.4 U.K.
7.5 Italy
7.6 Russia
7.7 Nordic Countries
7.8 Rest of Europe
8 Asia-Pacific
8.1 Asia-Pacific Anal and Colorectal Cancer Market Size by Region (2018-2029)
8.2 China
8.3 Japan
8.4 South Korea
8.5 Southeast Asia
8.6 India
8.7 Australia
8.8 Rest of Asia-Pacific
9 Latin America
9.1 Latin America Anal and Colorectal Cancer Market Size by Country (2018-2029)
9.2 Mexico
9.3 Brazil
9.4 Rest of Latin America
10 Middle East & Africa
10.1 Middle East & Africa Anal and Colorectal Cancer Market Size by Country (2018-2029)
10.2 Turkey
10.3 Saudi Arabia
10.4 UAE
10.5 Rest of Middle East & Africa
11 Anal and Colorectal Cancer Market Dynamics
11.1 Anal and Colorectal Cancer Industry Trends
11.2 Anal and Colorectal Cancer Market Drivers
11.3 Anal and Colorectal Cancer Market Challenges
11.4 Anal and Colorectal Cancer Market Restraints
12 Research Finding /Conclusion
13 Methodology and Data Source
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Disclaimer
13.4 Author List
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
